ENVISIONONE
Live / Registered — Registered (as of 11 Nov 2025)
What this means for you
Registered since 11 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98476408
- Registration number
- 8024979
- Mark type
- Stylized text
- Filed
- 30 Mar 2024
- Published for opposition
- 14 Jan 2025
- Registered
- 11 Nov 2025
- Attorney of record
- Zachary A. Aria
Goods and services
- Class 042 — Scientific and technological services: Web site hosting services for the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Software as a service (SAAS) services, namely, hosting software for use by others for improving the efficiency in which companies bring products to market in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Rental of software for improving the efficiency in which companies bring products to market in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Platform as a service (PAAS) featuring computer software platforms for improving the efficiency in which companies bring products to market in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Design, development and implementation of software and software platforms for the life science, pharmaceutical and bio-pharmaceutical industries and academic research organisations; Software development for others in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations in the field of software configuration management; Providing a web hosting platform for the life science, pharmaceutical and biopharmaceutical industries and academic research organisations; Installation, maintenance, repair and updating of computer software and computer software platforms for the life science, pharmaceutical and bio-pharmaceutical industries and academic research organisations; Design, development and implementation of software for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Software as a service (SAAS) services, namely, hosting software for global use by others for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Software development for others in the field of software configuration management for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Design, development and implementation of software platforms that incorporate integrated and configurable software modules for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Platform as a service (PAAS) featuring computer software platforms incorporating integrated and configurable software modules for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Software development for others in the field of software platform configuration management for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Technical support services, namely, technical advice related to the repair of computer software; Technical support services, namely, technical advice related to the maintenance of computer software; Consultancy services relating to software as a service (SAAS) services and the selection of software applications; Advisory, consultancy and information services relating to all the aforesaid services
Owner
- Envision Pharma Inc., Fairfield, CT, US
- Envision Pharma Inc., Fairfield, CT, US
- Envision Pharma Inc., Fairfield, CT, US
Prior registrations
Prosecution history
- 11 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 22 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Apr 2025 — USE AMENDMENT FILED
- 19 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jan 2025 — PUBLISHED FOR OPPOSITION
- 08 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED